There’s No Ebola Vaccine Yet Because We Cut the NIH Budget Ten Years Ago

Membership Ticker

You come to Mother Jones for unique journalism, and we love doing it for you—especially at a moment like this. That's really it. That's the upshot of our fall fundraising drive, and we're hoping to raise $250,000 in a much shorter than normal three-week window, by November 5, so we can keep right on doing it. Please pitch in early to help us get there.

$250,000

You come to Mother Jones for unique journalism, and we love doing it for you. That's it. That's the upshot of our fall fundraising drive, and we're hoping to raise $250,000 in a shorter than normal three-week window so we can keep right on doing it.

As we all know, the federal budget is bloated and wasteful. It needs to be cut across the board. Right?

Dr. Francis Collins, the head of the National Institutes of Health, said that a decade of stagnant spending has “slowed down” research on all items, including vaccinations for infectious diseases. As a result, he said, the international community has been left playing catch-up on a potentially avoidable humanitarian catastrophe.

“NIH has been working on Ebola vaccines since 2001. It’s not like we suddenly woke up and thought, ‘Oh my gosh, we should have something ready here,'” Collins told The Huffington Post on Friday. “Frankly, if we had not gone through our 10-year slide in research support, we probably would have had a vaccine in time for this that would’ve gone through clinical trials and would have been ready.”

Collins obviously has some skin in this game, but he’s probably right. What’s more, even without a vaccine we’d probably be better prepared to react to the Ebola outbreak if we hadn’t spent the past decade steadily slashing funding for public health emergencies. The chart on the right, from Scientific American, tells the story.

There are consequences for budget cuts. Right now we’re living through one of them.